Product Code: ETC6186115 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Neuroendovascular coils are used in endovascular procedures to treat aneurysms and other vascular diseases of the brain. The Australian market for these coils is growing due to the increasing prevalence of brain aneurysms and advancements in endovascular technology. Neuroendovascular coiling is considered a less invasive alternative to open surgery, and its adoption is on the rise due to its effectiveness and shorter recovery times. The market is driven by advancements in coil technology, improved patient outcomes, and the growing demand for minimally invasive neurovascular treatments.
The neuroendovascular coil market in Australia is seeing growth due to the rising prevalence of neurovascular conditions such as aneurysms and arteriovenous malformations. Endovascular coiling, which involves the insertion of coils into blood vessels to prevent hemorrhaging, is becoming a more common approach to treating these conditions. Advances in coil design and materials, along with improvements in catheter technologies, are driving the market forward. The trend toward minimally invasive procedures is expected to continue to support the growth of the neuroendovascular coil market.
The neuroendovascular coil market in Australia is challenged by factors such as the high cost of these specialized medical devices, which can limit their accessibility, especially in resource-constrained settings. Additionally, the complex nature of neuroendovascular procedures requires highly trained professionals, and there is a shortage of specialists in some regions. The risk of complications during procedures, such as coil migration or insufficient aneurysm occlusion, also presents challenges in the adoption of neuroendovascular coils. As with many other medical devices, regulatory approval processes can also slow the introduction of innovative products to the market.
With a growing emphasis on stroke prevention and treatment, the neuroendovascular coil market in Australia offers strong investment prospects. Opportunities lie in producing cost-effective, next-generation coils with enhanced navigability and safety. There is also increasing demand for hybrid devices and bioactive materials, making this a competitive yet rewarding area for medtech investors.
The Australian government regulates the neuroendovascular coil market through the TGA, ensuring that these medical devices meet the required safety and quality standards. Policies encourage research and development in the field of endovascular treatments for neurological conditions, with government funding available for innovation and clinical trials. Furthermore, Medicare coverage ensures that patients have access to these life-saving devices and treatments.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neuroendovascular Coil Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neuroendovascular Coil Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neuroendovascular Coil Market - Industry Life Cycle |
3.4 Australia Neuroendovascular Coil Market - Porter's Five Forces |
3.5 Australia Neuroendovascular Coil Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Neuroendovascular Coil Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Australia Neuroendovascular Coil Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Australia Neuroendovascular Coil Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Neuroendovascular Coil Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Neuroendovascular Coil Market Trends |
6 Australia Neuroendovascular Coil Market, By Types |
6.1 Australia Neuroendovascular Coil Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Neuroendovascular Coil Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Neuroendovascular Coil Market Revenues & Volume, By Guglielmi Detachable Coils (GDCs), 2021- 2031F |
6.1.4 Australia Neuroendovascular Coil Market Revenues & Volume, By Matrix Coils, 2021- 2031F |
6.2 Australia Neuroendovascular Coil Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Australia Neuroendovascular Coil Market Revenues & Volume, By Ruptured Aneurysm, 2021- 2031F |
6.2.3 Australia Neuroendovascular Coil Market Revenues & Volume, By Unruptured Aneurysm, 2021- 2031F |
6.3 Australia Neuroendovascular Coil Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia Neuroendovascular Coil Market Revenues & Volume, By Tumor Surgery, 2021- 2031F |
6.3.3 Australia Neuroendovascular Coil Market Revenues & Volume, By Medical Teaching, 2021- 2031F |
6.3.4 Australia Neuroendovascular Coil Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Neuroendovascular Coil Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Australia Neuroendovascular Coil Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Neuroendovascular Coil Market Revenues & Volume, By Ambulatory Surgical Centers (ASCs), 2021- 2031F |
6.4.4 Australia Neuroendovascular Coil Market Revenues & Volume, By Stroke Centers, 2021- 2031F |
6.4.5 Australia Neuroendovascular Coil Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Neuroendovascular Coil Market Import-Export Trade Statistics |
7.1 Australia Neuroendovascular Coil Market Export to Major Countries |
7.2 Australia Neuroendovascular Coil Market Imports from Major Countries |
8 Australia Neuroendovascular Coil Market Key Performance Indicators |
9 Australia Neuroendovascular Coil Market - Opportunity Assessment |
9.1 Australia Neuroendovascular Coil Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Neuroendovascular Coil Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Australia Neuroendovascular Coil Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Australia Neuroendovascular Coil Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Neuroendovascular Coil Market - Competitive Landscape |
10.1 Australia Neuroendovascular Coil Market Revenue Share, By Companies, 2024 |
10.2 Australia Neuroendovascular Coil Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |